CVS Group (LON:CVSG) Insider Richard Gray Purchases 2,000 Shares

CVS Group plc (LON:CVSG) insider Richard Gray acquired 2,000 shares of the business’s stock in a transaction dated Monday, January 5th. The stock was purchased at an average price of £1,276.96 per share, with a total value of £2,553,920.

CVS Group Price Performance

LON:CVSG traded up GBX 16.27 during mid-day trading on Tuesday, reaching GBX 1,292.27. The stock had a trading volume of 1,433,788 shares, compared to its average volume of 866,677. The firm has a 50 day moving average price of GBX 1,225.01 and a two-hundred day moving average price of GBX 1,247.24. The stock has a market capitalization of £918.00 million, a P/E ratio of 17.56, a P/E/G ratio of 1.77 and a beta of 1.02. CVS Group plc has a one year low of GBX 800 and a one year high of GBX 1,648. The company has a debt-to-equity ratio of 110.52, a quick ratio of 0.90 and a current ratio of 1.09.

CVS Group (LON:CVSG) last issued its quarterly earnings results on Tuesday, October 7th. The company reported GBX 80.10 EPS for the quarter. CVS Group had a net margin of 3.20% and a return on equity of 7.86%. As a group, analysts expect that CVS Group plc will post 93.9393939 earnings per share for the current year.

Analysts Set New Price Targets

Several equities analysts recently commented on the stock. Peel Hunt reaffirmed a “buy” rating and set a GBX 1,600 target price on shares of CVS Group in a report on Tuesday, November 18th. Deutsche Bank Aktiengesellschaft upped their price target on shares of CVS Group from GBX 1,500 to GBX 1,700 and gave the company a “buy” rating in a research report on Tuesday, October 21st. Jefferies Financial Group lifted their price objective on CVS Group from GBX 1,250 to GBX 1,420 and gave the stock a “hold” rating in a report on Wednesday, October 22nd. Berenberg Bank reissued a “buy” rating and issued a GBX 2,000 target price on shares of CVS Group in a research note on Tuesday, November 18th. Finally, Royal Bank Of Canada raised their price target on CVS Group from GBX 1,500 to GBX 1,900 and gave the stock an “outperform” rating in a research report on Tuesday, October 21st. Four research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of GBX 1,724.

CVS Group Company Profile

CVS Group is an AIM-listed provider of veterinary services with operations in the UK and Australia. CVS is focused on providing high-quality clinical services to its clients and their animals, with outstanding and dedicated clinical teams and support colleagues at the core of its strategy.

The Group now operates c.470 veterinary practices across its two territories, including specialist referral hospitals and dedicated out-of-hours sites. Alongside the core Veterinary Practices division, CVS operates Laboratories (providing diagnostic services to CVS and third-parties) and an online retail business (“Animed Direct”).

The Group employs c.8,900 personnel, including c.2,400 veterinary surgeons and c.3,300 nurses.